Total operating profit (loss)
McKesson·Business Segments·3 segments
Breakdown
| Segment | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| U.S. Pharmaceutical | $696.50M | $696.50M | $696.50M | $696.50M | $1.00B | $1.00B | $1.00B | $1.00B |
| Medical-Surgical Solutions | $238.00M | $238.00M | $238.00M | $238.00M | $193.25M | $193.25M | $193.25M | $193.25M |
| International | $79.75M | $79.75M | $79.75M | $79.75M | -$53.25M | -$53.25M | -$53.25M | -$53.25M |
| Total | $238.00M | $238.00M | $238.00M | $238.00M | $193.25M | $193.25M | $193.25M | $193.25M |
All segment values are derived from annual filings.